Company intelligence / Profile preview

ADDMEDICA

Paris, Île-de-France, Francepmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

ADDMEDICA is a privately owned specialty pharmaceutical company founded in Paris in 2005. It develops and markets medical products targeting rare diseases and serious conditions. The company's interests span wound healing, cell/tissue regeneration, organ transplantation support therapies, genetic disease treatments including cell/gene therapies. Some products are commercialized while others are under development.

Therapeutic areas: OtherRare Diseases
Modalities: Small molecules (implied by pharmaceutical focus)Cell therapy (mentioned as area of interest)Gene therapy (mentioned as area of interest)Drug or substitute therapy
Industry: Biotech

Drug pipeline

1 asset

hydroxyurea

Commercial

Indications: Sickle cell disease, Sickle cell anemia

Beyond the preview

Go deeper on ADDMEDICA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADDMEDICA.

Explore the full profile